Skip to main content
. 2007 Oct 17;8:397. doi: 10.1186/1471-2105-8-397

Table 2.

Structural assessment of the functional site predictions.1

LeuTAa rGAT1 rSERT hDAT Structural location Description Experimental evidence Predicted by2
(a.) Substrate/Na+-binding sites

G20 G59+ G94+ G75 TM1a Na+ binding site [2–95] P,S,R,E
N21 Y60+ Y95+ F76+ TM1a Leu binding site [94–99] None
A22 A61 A96 A77 TM1a Leu & Na+ binding sites None F,R
V23 I62+ V97 V78 Unwound TM1 Na+ binding site [95] F
G24 G63+ D98+ D79+ Unwound TM1 Leu binding site [95, 97, 100, 101] F,R,E,D
L25 L64+ L99+ L80+ TM1b Leu binding site [92, 95, 102] P,F,S,R,E
G26 G65+ G100+ A81 TM1b Leu binding site [92, 95] P,F,S,R
N27 N66+ N101+ N82 TM1b Na+ binding site [92, 95] P,F,S,R,E
E62 E101+ E136+ E117+ TM2 Stabilizes TM6 unwound region [55–58] P,F,S,R,E
V104 L136- I173+ V152+ TM3 Leu binding site [93, 96, 103–105] None
Y108 Y140+ Y176+ Y156+ TM3 Leu binding site [106–108] F,S,R
F252 F293 F334 C319+ TM6a Leu binding site [109] P,F,S,R
F253 F294+ F335+ F320+ TM6a Leu binding site [93, 98, 103, 110] P,F,S
T254 S295+ S336 S321+ TM6a Leu & Na+ binding sites [108, 110, 111] P,F,E
S256 G297 G338 G323+ Unwound TM6 Leu binding site [112] P,F,E
L257 L298+ P339+ V324 Unwound TM6 Leu binding site [110, 113] P
G258 G299 G340 G325+ Unwound TM6 Leu binding site [98] P
F259 L300 F341+ F326- Unwound TM6 Leu binding site [93, 98, 103] P
G260 G301 G342 G327+ Unwound TM6 Leu binding site [112] P,S,E
N286 N327+ N368 N353 TM7 Na+ binding site [111, 114] P,F,R
A351 L392 L434 L418 TM8 Na+ binding site None F,R,E,D
T354 D395+ D437 D42+ TM8 Na+ binding site [111, 115] P,F,R,E,D
S355 S396+ S438+ S422 TM8 Leu & Na+ binding sites [93, 103, 111] P,F,S,D
I359 T400 G442+ G426 TM8 Leu binding site [93, 103] None

(b.) Cytoplasmic gate

R5 R44+ R70 R60+ Cytoplasmic gate [116] S
W8 W47+ W82 W63+ Cytoplasmic gate [58, 116] S
S267 S308 S349 S334 Cytoplasmic gate None S,R,E
Y268 Y309- Y350 Y335+ Cytoplasmic gate [57, 106, 115] S,E
D369 D410 D452 D436+ Cytoplasmic gate [58, 115] S,E

(b.) Extracellular/periplasmic gate

R30 R69+ R104+ R85+ TM1b Extracellular gate [57, 92, 95, 97, 117] P,F,S,R,E
Y47 Y86+ Y121 Y102+ TM2 Extracellular gate [106, 108] P,F,S,R,E
Q250 Q291+ Q332 Q317+ TM6a Extracellular gate [57, 108, 110] P,F,S,R,E
E290 S331+ S372 L355 TM7 Extracellular gate [111, 114] P
D404 D451 E493+ D476+ TM10 Extracellular gate [58, 104] P,S

1 The importance of the functional site benchmark has been clearly established by Yamashita et al. from the LeuTAa structure [10]. Residue numbers correspond to those of LeuTAa, rGAT1, rSERT, and hDAT (columns 1–4, respectively). Residues shown in bold with + are those whose functional role is supported by experimental data. Residues shown in bold with - are those whose functional role is not supported by experimental data. Our literature search failed to find mutagenesis evidence for residues without boldface. The criterion for positive experimental confirmation was a minimum of two-fold reduction in substrate uptake rate and/or affinity of the single site mutant compared to WT.2 Six unique bioinformatic approaches were utilized in order to predict functional sites within the NSS family. The methods employed are: P = phylogenetic motif, F = false positive expectation, S = site conservation, R = Rate4Site, E = evolutionary trace, and D = SDPpred.